Terms: = Lung cancer AND TP53, TRP53, 7157, ENSG00000141510, P04637, LFS1, P53 AND Treatment
2371 results:
1. The tp53-activated E3 ligase RNF144B is a tumour suppressor that prevents genomic instability.
Abad E; Sandoz J; Romero G; Zadra I; Urgel-Solas J; Borredat P; Kourtis S; Ortet L; Martínez CM; Weghorn D; Sdelci S; Janic A
J Exp Clin Cancer Res; 2024 Apr; 43(1):127. PubMed ID: 38685100
[TBL] [Abstract] [Full Text] [Related]
2. QiDongNing induces lung cancer cell apoptosis via triggering p53/DRP1-mediated mitochondrial fission.
Ding R; Wang Y; Xu L; Sang S; Wu G; Yang W; Zhang Y; Wang C; Qi A; Xie H; Liu Y; Dai A; Jiao L
J Cell Mol Med; 2024 May; 28(9):e18353. PubMed ID: 38682742
[TBL] [Abstract] [Full Text] [Related]
3. Comprehensive genomic profiling of pulmonary spindle cell carcinoma using tissue and plasma samples: insights from a real-world cohort analysis.
Sun Y; Qin S; Wang S; Pang J; Ou Q; Liang W; Zhong H
J Pathol Clin Res; 2024 May; 10(3):e12375. PubMed ID: 38661052
[TBL] [Abstract] [Full Text] [Related]
4. Proteasome activation is critical for cell death induced by inhibitors of polo-like kinase 1 (PLK1) in multiple cancers.
Wang Y; Wang G; Xiang W; Liu X; Jiang M; Hu J
Eur J Pharmacol; 2024 Jun; 972():176558. PubMed ID: 38614382
[TBL] [Abstract] [Full Text] [Related]
5. Proteogenomic Characterization Reveals Estrogen Signaling as a Target for Never-Smoker lung Adenocarcinoma Patients without EGFR or ALK Alterations.
Park SJ; Ju S; Goh SH; Yoon BH; Park JL; Kim JH; Lee S; Lee SJ; Kwon Y; Lee W; Park KC; Lee GK; Park SY; Kim S; Kim SY; Han JY; Lee C
Cancer Res; 2024 May; 84(9):1491-1503. PubMed ID: 38607364
[TBL] [Abstract] [Full Text] [Related]
6. [Clinical characteristics and prognosis analysis of pulmonary sarcomatoid carcinoma].
Feng XY; Chen MJ; Xu Y; Zhong W; Liu XY; Gao XX; Zhao J; Wang MZ
Zhonghua Jie He He Hu Xi Za Zhi; 2024 Apr; 47(4):319-324. PubMed ID: 38599806
[No Abstract] [Full Text] [Related]
7. Hibiscus manihot L. flower extract induces anticancer activity through modulation of apoptosis and autophagy in A549 cells.
Xu M; Zhao M; Zhu M; Yuan H; Li Z; Yan P; Ma C; Zhao H; Wang S; Wan R; Wang L; Yu G
Sci Rep; 2024 Apr; 14(1):8102. PubMed ID: 38582921
[TBL] [Abstract] [Full Text] [Related]
8. Comprehensive analysis and validation reveal DEPDC1 as a potential diagnostic biomarker associated with tumor immunity in non-small-cell lung cancer.
Lv M; Li X; Yin Z; Yang H; Zhou B
PLoS One; 2024; 19(4):e0294227. PubMed ID: 38564630
[TBL] [Abstract] [Full Text] [Related]
9. Nanoparticles targeting mutant p53 overcome chemoresistance and tumor recurrence in non-small cell lung cancer.
Bi YY; Chen Q; Yang MY; Xing L; Jiang HL
Nat Commun; 2024 Mar; 15(1):2759. PubMed ID: 38553451
[TBL] [Abstract] [Full Text] [Related]
10. Evolutionary trajectories of small cell lung cancer under therapy.
George J; Maas L; Abedpour N; Cartolano M; Kaiser L; Fischer RN; Scheel AH; Weber JP; Hellmich M; Bosco G; Volz C; Mueller C; Dahmen I; John F; Alves CP; Werr L; Panse JP; Kirschner M; Engel-Riedel W; Jürgens J; Stoelben E; Brockmann M; Grau S; Sebastian M; Stratmann JA; Kern J; Hummel HD; Hegedüs B; Schuler M; Plönes T; Aigner C; Elter T; Toepelt K; Ko YD; Kurz S; Grohé C; Serke M; Höpker K; Hagmeyer L; Doerr F; Hekmath K; Strapatsas J; Kambartel KO; Chakupurakal G; Busch A; Bauernfeind FG; Griesinger F; Luers A; Dirks W; Wiewrodt R; Luecke A; Rodermann E; Diel A; Hagen V; Severin K; Ullrich RT; Reinhardt HC; Quaas A; Bogus M; Courts C; Nürnberg P; Becker K; Achter V; Büttner R; Wolf J; Peifer M; Thomas RK
Nature; 2024 Mar; 627(8005):880-889. PubMed ID: 38480884
[TBL] [Abstract] [Full Text] [Related]
11. Metformin and buparlisib synergistically induce apoptosis of non-small lung cancer (NSCLC) cells via Akt/FoxO3a/Puma axis.
Shanshan W; Hongying M; Jingjing F; Rui Y
Toxicol In Vitro; 2024 May; 97():105801. PubMed ID: 38479708
[TBL] [Abstract] [Full Text] [Related]
12. Clinicopathologic features, concurrent genomic alterations, and clinical outcomes of patients with KRAS G12D mutations in resected lung adenocarcinoma.
Cao H; Ma Z; Huang Q; Han H; Li Y; Zhang Y; Chen H
Eur J Cancer; 2024 May; 202():113985. PubMed ID: 38452722
[TBL] [Abstract] [Full Text] [Related]
13. Emerging role of tumor suppressing microRNAs as therapeutics in managing non-small cell lung cancer.
Singh S; Saxena S; Sharma H; Paudel KR; Chakraborty A; MacLoughlin R; Oliver BG; Gupta G; Negi P; Singh SK; Dua K
Pathol Res Pract; 2024 Apr; 256():155222. PubMed ID: 38452582
[TBL] [Abstract] [Full Text] [Related]
14. Exploration of Ginkgo biloba leaves on non-small cell lung cancer based on network pharmacology and molecular docking.
Wang M; Li R; Bai M; Zhou X
Medicine (Baltimore); 2024 Mar; 103(9):e37218. PubMed ID: 38428907
[TBL] [Abstract] [Full Text] [Related]
15. Updated overall survival and circulating tumor DNA analysis of ensartinib for crizotinib-refractory ALK-positive NSCLC from a phase II study.
Zheng J; Wang T; Yang Y; Huang J; Feng J; Zhuang W; Chen J; Zhao J; Zhong W; Zhao Y; Zhang Y; Song Y; Hu Y; Yu Z; Gong Y; Chen Y; Ye F; Zhang S; Cao L; Fan Y; Wu G; Guo Y; Zhou C; Ma K; Fang J; Feng W; Liu Y; Zheng Z; Li G; Wang H; Cang S; Wu N; Song W; Liu X; Zhao S; Ding L; Selvaggi G; Wang Y; Xiao S; Wang Q; Shen Z; Zhou J; Zhou J; Zhang L
Cancer Commun (Lond); 2024 Apr; 44(4):455-468. PubMed ID: 38421881
[TBL] [Abstract] [Full Text] [Related]
16. The role of leptin in regulation of the soluble amyloid precursor protein α (sAPPα) levels in lung cancer cell media.
Haddad B; Khalil J; Al Khashali H; Ray R; Goel S; Darweesh B; Coleman KL; Wozniak C; Ranzenberger R; Lopo B; Guthrie J; Heyl D; Evans HG
Sci Rep; 2024 Feb; 14(1):4921. PubMed ID: 38418632
[TBL] [Abstract] [Full Text] [Related]
17. EGFR and ERBB2 Exon 20 Insertion Mutations in Chinese Non-small Cell lung cancer Patients: Pathological and Molecular Characterization, and First-Line Systemic treatment Evaluation.
Zhao R; Li J; Guo L; Xiang C; Chen S; Zhao J; Shao J; Zhu L; Ye M; Qin G; Chu T; Han Y
Target Oncol; 2024 Mar; 19(2):277-288. PubMed ID: 38416376
[TBL] [Abstract] [Full Text] [Related]
18. Next-Generation Sequencing in lung cancers-A Single-Center Experience in Taiwan.
Lai WA; Huang YS; Chang KC; Yang SF; Yang CJ; Liu YW; Chen HD
Medicina (Kaunas); 2024 Jan; 60(2):. PubMed ID: 38399524
[No Abstract] [Full Text] [Related]
19. Developing Folate-Conjugated miR-34a Therapeutic for Prostate cancer: Challenges and Promises.
Li WJ; Wang Y; Liu X; Wu S; Wang M; Turowski SG; Spernyak JA; Tracz A; Abdelaal AM; Sudarshan K; Puzanov I; Chatta G; Kasinski AL; Tang DG
Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38396800
[TBL] [Abstract] [Full Text] [Related]
20. Molecular mechanisms underlying the regulation of tumour suppressor genes in lung cancer.
Lee JY; Bhandare RR; Boddu SHS; Shaik AB; Saktivel LP; Gupta G; Negi P; Barakat M; Singh SK; Dua K; Chellappan DK
Biomed Pharmacother; 2024 Apr; 173():116275. PubMed ID: 38394846
[TBL] [Abstract] [Full Text] [Related]
[Next]
